CJC-1295 + Ipamorelin blend vs Tesamorelin: a research overview

One listing is a single vial holding two different peptides; the other is a single 44-residue chain. This page compares them strictly as documentation problems: what each component is, what mass it should show, and what a certificate of analysis has to contain before it describes the vial it names.

Research-use scope. This page describes laboratory research materials and their analytical documentation. It is not for use in people or animals, contains no handling, preparation, or procedural guidance, and makes no claim that any material named here is safe or effective for any purpose. It compares identity and documentation only; it does not compare, rank, or recommend the materials for any application.

Three molecules, two listings

CJC-1295 without DAC, also called modified GRF (1-29), keeps the first 29 residues of growth-hormone-releasing hormone with four substitutions (D-alanine at position 2, glutamine at 8, alanine at 15, leucine at 27) and a C-terminal amide. Tesamorelin keeps all 44 residues of the same parent and adds a trans-3-hexenoyl group to the N-terminus. Ipamorelin is unrelated in structure: a five-residue chain built largely from non-protein residues. The CJC-1295 + Ipamorelin 10mg listing combines the first and third in one vial; the Tesamorelin 10mg listing is the second on its own.

PropertyCJC-1295 (no DAC)IpamorelinTesamorelin
Residue count29544, plus an N-terminal acyl group
EndsFree N-terminus; C-terminal amideC-terminal amidetrans-3-Hexenoyl N-terminus; C-terminal amide
Non-standard residuesD-alanine at position 2Aib, D-2-naphthylalanine, D-phenylalanineNone in the chain
Molecular formulaC152H252N44O42C38H49N9O5C221H366N72O67S
CAS registry number863288-34-0170851-70-4218949-48-5
Theoretical average mass3,367.9 g/mol711.9 g/molabout 5,136 g/mol
Theoretical monoisotopic massapproximately 3,365.9approximately 711.4approximately 5,132.7
Ions a mass spectrum typically showsMultiply charged: near m/z 1,123.0 (3+), 842.5 (4+), 674.2 (5+)near m/z 712.4 (1+) and 356.7 (2+)Multiply charged: near m/z 1,284.2 (4+), 1,027.6 (5+), 856.5 (6+)
Sulfur in the formulaNone (leucine replaces the parent's methionine at 27)NoneOne (methionine at position 27)
Physical form suppliedLyophilized solid

Formulas and CAS numbers are the ones published on the single-compound listings (CJC-1295 (No DAC) 5mg, Ipamorelin 10mg, Tesamorelin 10mg); the ions are calculated from them. The blend listing states a total of 10 mg; the report for a blend lot should state the measured content of each component.

A blend is two documentation problems in one vial

A single-compound certificate assumes one intended peak. A blend breaks that assumption, as set out in what a blend COA has to show. For this pair, that means:

Tesamorelin: one long chain and the group on its end

What each certificate of analysis must show

Report sectionFor a CJC-1295 + Ipamorelin blend lotFor a Tesamorelin lot
IdentityTwo results: a mass in agreement with 3,367.9 g/mol for CJC-1295 (no DAC) and with 711.9 g/mol for Ipamorelin, with charge states listed, or HPLC-RTM against two named reference standardsDeconvoluted mass in agreement with about 5,136 g/mol within tolerance, with the charge states listed, or HPLC-RTM against a named tesamorelin reference standard
Chromatographic purityPurity for each component, or a stated composition, with both intended peaks assigned on the published chromatogramMain-peak area as a percentage of total integrated area, with the chromatogram published; expect a family of near-eluting deletion peaks and check for a +16 oxidation peak
Net contentMeasured mg of each component, and their sum compared with the labeled 10 mg totalMeasured mg of peptide in the vial, stated next to the labeled strength
EndotoxinWhere tested: the method (LAL, with the USP <85> reference if claimed), the result with its units (EU per mL, per mg or per vial), and the limit it was compared against.
Heavy metalsWhere tested: the elements in the panel, the method, and a result or "none detected" against a stated reporting limit.
Method fieldsColumn, mobile phase or gradient, detection wavelength, and reporting limit. A percentage with no method attached is not a result.
Record fieldsMaterial name, labeled strength, lot identifier matching the vial label, test date, certificate or accession number, and the issuing laboratory with its verification route.

Endotoxin and heavy-metal screens are only part of a report when the laboratory ran them. If a line is not on the certificate, that test was not performed on that lot; it has not been passed. The endotoxin testing guide explains what a LAL result and a USP <85> pass mean, and net peptide content explains why the measured mg can differ from the label.

How to read our reports for these listings

Our current reports come from three laboratories. Freedom Diagnostics reports give purity by HPLC-UV, identity by LC-MS, net content in mg, and an endotoxin result where one is listed; each carries an accession number and a search code for the laboratory's lookup page. ILS Laboratories reports give purity by HPLC, identity by retention-time match against a reference standard, net peptide content, and the screens run on that lot. Janoshik Analytical reports carry the laboratory's own verification key. Verify a lab report walks through each lookup.

On Arctic Lab Supply reports. Every currently published report is listed in the batch COA library with its certificate or accession number and verification link. The report for the lot you receive is the one that governs; where an earlier lot's figures differ, the lot-specific report is authoritative.

Common questions

How does a CJC-1295 + Ipamorelin blend report differ from a Tesamorelin report?

The blend report has to identify two compounds, CJC-1295 without DAC (C152H252N44O42, 3,367.9 g/mol) and Ipamorelin (C38H49N9O5, 711.9 g/mol), and give purity or composition and net content for each. A Tesamorelin report describes one 44-residue chain (C221H366N72O67S, about 5,136 g/mol) and has to confirm its N-terminal hexenoyl group.

What masses should each report state?

CJC-1295 (no DAC): about 3,365.9 monoisotopic or 3,367.9 g/mol average, usually seen as multiply charged ions near m/z 1,123.0, 842.5 and 674.2. Ipamorelin: about 711.4 or 711.9 g/mol, near m/z 712.4 and 356.7. Tesamorelin: about 5,132.7 or 5,136 g/mol, near m/z 1,284.2, 1,027.6 and 856.5.

Why can one purity figure not describe a two-peptide blend?

Purity is the main peak as a share of everything detected. In a blend two peaks are supposed to be there, so one figure would count one component as an impurity of the other. The report needs purity or composition per component, both peaks assigned on the chromatogram, and net content for each.

Which of these lots are documented on this site?

Tesamorelin 10mg lot TS-2502B (99.84%, Freedom Diagnostics, Oct 15, 2026) and Ipamorelin 10mg lot IPA-2510-A (99.83%, Nov 1, 2026) have published reports. The CJC-1295 + Ipamorelin 10mg blend was listed in November 2026; its lot report is posted on the product page and in the COA library when it is back.

Related documentation